On February 17, 2026, Alpine Global Management disclosed a sale of 127,039 shares of immunovant (NASDAQ:IMVT)with an estimated transaction value of $2.83 million based on the quarterly average price. According to a filing with the Securities and Exchange Commission on February 17, 2026, Alpine Global Management reduced its position in Immunovant by 127,039 shares during…
We came across a bullish thesis on Vera Therapeutics, Inc. at Valueinvestorsclub.com from yarak775. In this article we will summarize the bulls’ thesis about VERA. Vera Therapeutics, Inc. stock was trading at $45.11 on January 28. Adaptive biotechnologies (ADPT) peak in three years. here’s why Pressmaster/Shutterstock.com Vera Therapeutics (VERA) is a clinical-stage biotechnology company focused…
Swiss drugmaker Novartis said on Sunday it has agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash, as the company looks to bolster its portfolio of treatments for rare muscle disorders. Under the terms of the deal, Avidity shareholders will receive $72 per share in cash, representing a 46% premium…
By Padmanabhan Ananthan and Angela Christy M. (Reuters) -Swiss drugmaker Novartis said on Sunday it has agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash, as the company seeks to bolster its portfolio of treatments for rare muscle disorders. Under the terms of the deal, Avidity shareholders will receive $72…
Benzinga and Yahoo Finance LLC may earn commissions or revenue on some articles through the links below. Well theoryA female-founded health tech startup that uses artificial intelligence to transform autoimmune care, announced Tuesday that it has secured $14 million in Series A funding. The round was led by General catalystwith the participation of 7wire companies,…
